Description
DMeOB is a negative allosteric modulator of metabotropic glutamate 5 (mGlu5) receptor. It exhibits reversible non-competitive inhibition of mGlu5-mediated responses (IC50 = 3 µM). mGluR is the promising target for neurological disorder treatment